Advances in Enabling Smart Technologies across the Cell Therapy Supply Chain

In by

Spotlight Article

Interview

Maria Papathanasiou

SUPPLY CHAIN MANAGEMENT PART 2: CREATING A LOGISTICS STRATEGY FOR COMMERCIALIZATION

Papathanasiou headshot

Maria Papathanasiou holds a PhD degree in Chemical Engineering and is currently a full-time Research Associate at the Department of Chemical Engineering at Imperial College London, working with Professor Nilay Shah. Her primary research focus is the modeling and optimization of CAR T cell supply chain models, with four key objectives: (i) scalability, (ii) cost efficiency, (iii) timely delivery of therapies and (iv) minimization of risk of product loss. Other research areas include the development of mathematical tools for optimization, monitoring and control in pharmaceutical and biopharmaceutical manufacturing.

DOI: 10.18609/cgti.2018.050
Citation: Cell Gene Therapy Insights 2018; 4(5), 495-500.
Open access

This content is restricted to registered users. Click here to Register or Login here.